Cbdmd Inc 's

The dietary supplement market, particularly the hemp-derived cannabinoid segment, is highly competitive and fragmented, with over 2,000 brands and no clear dominant brand in the United States. Competitors include both public and private companies operating through e-commerce, wholesale, and brick-and-mortar retail channels. The market features products such as hemp-derived CBD, Delta 9, and synthetic compounds including delta-8, delta-10, and HHC, which have recently gained market share. The company also competes in its functional mushroom and beverage lines, ATRx and Oasis, within the fast-growing dietary supplement and CBD sectors. Pending federal law changes may reduce competition by causing smaller, poorly capitalized, or non-compliant competitors to exit the market.